Applied StemCell Strengthens Executive Leadership with Two Key Appointments
December 04, 2023 9:00 AM PST MILPITAS, Calif.–Applied StemCell, Inc., a leading CRO/CDMO recognized for its proprietary TARGATT™ gene editing technology and expertise in stem cells and cell therapy development, is pleased to announce the addition of two accomplished professionals to its C-level executive team: George Hong (Chief Commercial Officer) and Timothy J. Largen (Chief […]